See more : Alps Logistics Co., Ltd. (9055.T) Income Statement Analysis – Financial Results
Complete financial analysis of Harvest Health & Recreation Inc. (HRVSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harvest Health & Recreation Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Mitsui & Co., Ltd. (MITSF) Income Statement Analysis – Financial Results
- BlackRock MuniYield Fund, Inc. (MYD) Income Statement Analysis – Financial Results
- Inter State Oil Carrier Limited (INTSTOIL.BO) Income Statement Analysis – Financial Results
- Tianjin MOTIMO Membrane Technology Co.,Ltd (300334.SZ) Income Statement Analysis – Financial Results
- SENA J Property Public Company Limited (SENAJ.BK) Income Statement Analysis – Financial Results
Harvest Health & Recreation Inc. (HRVSF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.harvesthoc.com
About Harvest Health & Recreation Inc.
Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 231.46M | 116.78M | 77.79K | 200.29K | 284.45K | 482.02K | 675.22K | 368.83K | 292.64K | 233.88K | 180.62K | 147.97K | 24.10K |
| Cost of Revenue | 129.87M | 73.21M | 15.89K | 56.47K | 31.73K | 94.81K | 160.79K | 51.74K | 269.58K | 478.39K | 372.72K | 1.23M | 14.92K |
| Gross Profit | 101.59M | 43.57M | 61.91K | 143.82K | 252.72K | 387.20K | 514.43K | 317.09K | 23.05K | -244.51K | -192.10K | -1.08M | 9.18K |
| Gross Profit Ratio | 43.89% | 37.31% | 79.58% | 71.81% | 88.84% | 80.33% | 76.19% | 85.97% | 7.88% | -104.55% | -106.36% | -728.50% | 38.10% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.10M | 115.86M | 83.35K | 65.96K | 78.32K | 129.18K | 251.07K | 246.79K | 446.60K | 505.30K | 498.98K | 498.25K | 0.00 |
| Selling & Marketing | 4.96M | 8.94M | 0.00 | 0.00 | 0.00 | 0.00 | 1.40K | 0.00 | 1.26K | 0.00 | 10.93K | 0.00 | 0.00 |
| SG&A | 127.06M | 124.80M | 83.35K | 65.96K | 78.32K | 129.18K | 252.46K | 246.79K | 447.86K | 505.30K | 509.91K | 498.25K | 0.00 |
| Other Expenses | 7.92M | 10.30M | 93.75K | 126.55K | 300.84K | 408.79K | 308.00K | 180.03K | 55.80K | 0.00 | 0.00 | 0.00 | 1.46M |
| Operating Expenses | 134.98M | 135.10M | 177.10K | 192.51K | 379.15K | 537.97K | 560.47K | 426.82K | 503.65K | 505.30K | 509.91K | 498.25K | 1.46M |
| Cost & Expenses | 264.85M | 208.30M | 192.98K | 248.98K | 410.89K | 632.79K | 721.26K | 478.56K | 773.24K | 983.69K | 882.64K | 1.72M | 1.48M |
| Interest Income | 444.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.03 | 615.56 | 568.96 | 1.21K | 1.98K | 9.68K | 1.53K |
| Interest Expense | 39.06M | 16.24M | 4.78K | 5.50K | 3.34K | 5.27K | 6.99K | 10.34K | 32.61K | 27.68K | 16.64K | 2.28K | 0.00 |
| Depreciation & Amortization | 16.67M | 12.69M | 2.93K | 5.22K | 3.29K | 13.51K | 24.44K | 6.09K | 55.80K | 200.11K | 165.86K | 991.47K | 651.57K |
| EBITDA | -259.00K | -140.80M | -347.62K | -43.47K | -109.40K | -110.67K | -219.74K | -125.25K | -25.86K | -645.52K | -1.56M | -575.04K | -801.24K |
| EBITDA Ratio | -0.11% | -120.57% | -446.85% | -21.71% | -38.46% | -22.96% | -32.54% | -33.96% | -8.84% | -276.01% | -866.36% | -388.63% | -3,324.16% |
| Operating Income | -33.39M | -91.52M | -115.19K | -48.69K | -126.44K | -150.77K | -46.04K | -109.73K | -480.60K | -749.81K | -702.02K | -1.58M | -1.45M |
| Operating Income Ratio | -14.43% | -78.37% | -148.07% | -24.31% | -44.45% | -31.28% | -6.82% | -29.75% | -164.23% | -320.60% | -388.67% | -1,065.22% | -6,033.34% |
| Total Other Income/Expenses | -21.26M | -80.29M | -240.14K | -5.50K | 10.40K | 21.32K | -205.13K | -31.96K | 366.34K | -97.03K | -933.72K | 0.00 | 0.00 |
| Income Before Tax | -54.65M | -171.81M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -846.84K | -1.64M | 0.00 | 0.00 |
| Income Before Tax Ratio | -23.61% | -147.12% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -362.08% | -905.63% | 0.00% | 0.00% |
| Income Tax Expense | 3.65M | 3.76M | -235.36K | 0.00 | 13.75K | 26.59K | -198.14K | -21.61K | 398.95K | -69.35K | -917.09K | 2.28K | 0.00 |
| Net Income | -59.63M | -173.49M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -873.31K | -1.75M | -1.57M | -1.45M |
| Net Income Ratio | -25.76% | -148.56% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -373.40% | -967.40% | -1,060.22% | -6,027.36% |
| EPS | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
| EPS Diluted | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
| Weighted Avg Shares Out | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
| Weighted Avg Shares Out (Dil) | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
Should You Be Buying These Marijuana Stocks During This Decline In The Market?
Pot Stocks With Possible Upside In May The post Should You Be Buying These Marijuana Stocks During This Decline In The Market? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Alabama Legalizes Medical Marijuana
The state becomes the 37th sanctioning marijuana to some degree.
Is Trulieve a Must-Buy After Announcing Plans to Acquire Harvest Health?
The acquisition will instantly give it a large footprint in Arizona.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Harvest Health & Recreation, Inc. - HRVSF
NEW YORK, May 14, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New...
HARVEST HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harvest Health & Recreation Inc. - HRVSF
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Harvest Health & Recreation Inc. (OTC: HRVSF) to Trulieve Cannabis Corp....
Analyst: Trulieve's Harvest Merger Wouldn't Have Been Cantor's 'First Choice' But It Brings More Value Than Just Assets
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced Monday it will buy Harvest Health & Recreation Inc. (CSE: HARV) (OTCQX: HRVSF) for a whopping $2.1 billion in an all-stock deal. Under the merger agreement, Harvest shareholders will acquire 0.1170 of subordinate voting...
Harvest Health Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Harvest Health & Recreation Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – HRVSF
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Harvest Health & Recreation Inc. (OTCQX: HRVSF) to Trulieve Cannabis Corp. is fair to Harvest Health shareholders. Under the terms of the agreement,...
Trulieve Cannabis Acquiring Harvest Health & Recreation in $2.1 Billion Deal
The deal creates a new marijuana industry powerhouse.
These Marijuana Companies Are Now The Biggest In The World
These Cannabis Companies Are Making Big Waves In The Industry The post These Marijuana Companies Are Now The Biggest In The World appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Harvest Health & Recreation Inc.
NEW YORK, May 10, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Harvest Health & Recreation Inc. ("Harvest" or the "Company") (OTC: HRVSF) in connection with the...
Source: https://incomestatements.info
Category: Stock Reports